Evidence map›Paper›PMID 41361251›Full record

ArticleBMC gastroenterology2025

Endoscopic resection for small rectal gastrointestinal stromal tumors: a pilot study.

Kedinuer Abulaiti, Bing Li, Yingjie Liu, Bahejuan Jiaerken, Yongbing Li, Zhipeng Qi, Yunshi Zhong, Pinghong Zhou, Qiang Shi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kedinuer Abulaiti *Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.
Bing Li *Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.
Yingjie Liu *Endoscopy Center, Geermu Jianqiao Hospital, Qinghai, 816000, China.
Bahejuan JiaerkenEndoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.
Yongbing LiEndoscopy Center, Geermu Jianqiao Hospital, Qinghai, 816000, China.
Zhipeng QiEndoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.
Yunshi ZhongEndoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.
Pinghong ZhouEndoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China.
Qiang ShiEndoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Xuhui District, Shanghai, 200032, China. shi.qiang@zs-hospital.sh.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRectal gastrointestinal stromal tumors are a rare subset of gastrointestinal stromal tumors with malignant potential, making their management clinically challenging. This study sought to assess the feasibility, safety, and efficacy of endoscopic resection as a primary treatment for these tumors.

methodsThis study conducted a retrospective analysis and follow-up of clinical data from 18 patients who were diagnosed with rectal gastrointestinal stromal tumors (GISTs) and who underwent endoscopic resection at Zhongshan Hospital, affiliated with Fudan University, from February 2018 to May 2025. This study aimed to outline the clinicopathological characteristics, endoscopic diagnostic approaches, and therapeutic insights specific to rectal GIST patients.

resultsA series of 18 rectal GIST patients underwent endoscopic resection with 100% success in achieving en bloc and R0 resection. The cohort had a 1:1 gender ratio and a mean age of 56. Most (77.8%) were asymptomatic. All the tumors were solitary, peri-anal lesions (4–35 mm). The procedures were efficient (median: 37.5 min) and safe, with no intraoperative complications. Three minor postoperative issues arose but were self-limiting. The median hospitalization duration was 3 days, and notably, no recurrence was found after a median 29-month follow-up.

conclusionAlthough based on a small cohort, endoscopic resection proved feasible and safe for small rectal GISTs (≤ 3 cm), achieving high complete resection and no recurrence. This provides preliminary support for its use, pending confirmation in larger comparative trials.

Indexed as

Gastrointestinal Stromal TumorsRectal NeoplasmsAdultAgedFeasibility StudiesFemaleFollow-Up StudiesHumansLength of StayMaleMiddle AgedPilot ProjectsRetrospective StudiesTreatment OutcomeClinical manifestationEndoscopic featuresEndoscopic resectionRectal gastrointestinal stromal tumors

Identifiers

PMID41361251
PMCPMC12801792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.